Name : Mr.
Lab No. DUMMY : Age : 25 Years
Ref By WM17SPF Gender : Male
Collected : SELF Reported : 17/1/2024 10:55:48AM
A/c Status : 7/11/2023 Report Status : Revised
Collected at 11:08:00AM : P Processed at : LPL-NATIONAL REFERENCE LAB
: LPL-ROHINI (NATIONAL REFERENCE LAB) National Reference laboratory, Block E,
National Reference laboratory, Block E, Sector 18, Rohini, New Delhi -110085
Sector 18, ROHINI
DELHI 110085
Test Report
Test Name Results Units Bio. Ref Interval
SWASTHFIT SUPER 4
LIVER & KIDNEY PANEL, SERUM
1.00
Creatinine mg/dL 0.70 -
1.30
(Modified
107
Jaffe,Kinetic) GFR mL/min/
Estimated
G1
(CKD EPI Equation
2021) GFR Category
(KDIGO Guideline 40.00
mg/ 13.00 -
(Urease UV) dL 43.00
18.68
Urea Nitrogen
Blood (Calculated)
19
BUN/Creatinine
Ratio (Calculated)
Uric Acid mg/ 3.50 - 7.20
(Uricase) dL
30.0
AST (SGOT) 15.00 -
U/L 40.00
(IFCC without
P5P) ALT 40.0
(IFCC without P5P) U/L 10.00 -
49.00
50.0
GG
U/L
TP 0 - 73
100.00
(IFC
(IFCC-AMP) U/L
30.00 -
1.00 120.00
Bilirubin
mg/
Total dL
0.20 0.30 - 1.20
(Oxidation)
Bilirubin mg/
0.80 dL <0.3
Direct
(Oxidation)
Bilirubin Indirect 8.00 <1.10
mg/
(Calculate dL
d) Total 4.00 5.70 - 8.20
Protein
(Biuret) 1.00 3.20 - 4.80
Albu
min 4.00 0.90 - 2.00
gm/
(BCG dL
) 9.00 2.0 - 3.5
Ⅱ 忄ⅡⅡⅡⅡⅡⅡⅡ
A :G
8.70 - 10.40
Name : Mr.
Lab No. DUMMY : Age : 25 Years
Ref By WM17SPF Gender : Male
Collected : SELF Reported : 17/1/2024 10:55:48AM
A/c Status : 7/11/2023 Report Status : Revised
Collected at 11:08:00AM : P Processed at : LPL-NATIONAL REFERENCE LAB
: LPL-ROHINI (NATIONAL REFERENCE LAB) National Reference laboratory, Block E,
National Reference laboratory, Block E, Sector 18, Rohini, New Delhi -110085
Sector 18, ROHINI
DELHI 110085
Test Report
Test Name Results Units Bio. Ref Interval
Phosphorus 4.00 mg/dL 2.40 - 5.10
(Molybdate UV)
Sodium 140.00 mEq/L 136.00 - 145.00
(Indirect ISE)
Potassium 4.00 mEq/L 3.50 - 5.10
(Indirect ISE)
Chloride 100.00 mEq/L 98.00 - 107.00
(Indirect ISE)
LIPID SCREEN, SERUM
Cholesterol, Total 100.00 mg/dL <200.00
(CHO-POD)
Triglycerides 100.00 mg/dL <150.00
(GPO-POD)
HDL Cholesterol 30.00 mg/dL >40.00
(Enz Immunoinhibition)
LDL Cholesterol, Calculated 50.00 mg/dL <100.00
(Calculated)
VLDL Cholesterol,Calculated 20.00 mg/dL <30.00
(Calculated)
Non-HDL Cholesterol 70 mg/dL <130
(Calculated)
Note
1. Measurements in the same patient can show physiological & analytical variations. Three serial
samples 1 week apart are recommended for Total Cholesterol, Triglycerides, HDL& LDL Cholesterol.
2. Additional testing for Apolipoprotein B, hsCRP, Lp(a ) & LP-PLA2 should be considered
among patients with moderate risk for ASCVD for risk refinement.
Treatment Goals as per Lipid Association of India 2020
RISK | TREATMENT GOAL | CONSIDER THERAPY
CATEGORY |----------------------------------------- |-------------------------------------
| LDL CHOLESTEROL | NON HDL CHLOESTEROL| LDL CHOLESTEROL| NON HDL CHLOESTEROL
| (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL) | (LDL-C)(mg/dL) | (NON HDL-C) (mg/dL)
------------ |-------------------- |-------------------- |---------------- |--------------------
Extreme | <50 | <80 | |
Risk Group |(Optional goal ≤30) |(Optional goal ≤60) | ≥50 | ≥80
Category A | | | |
------------ |-------------------- |-------------------- |---------------- |--------------------
Extreme | | | |
Risk Group | ≤30 | ≤60 | >30 | >60
Category A | | | |
------------ |-------------------- |-------------------- |---------------- |--------------------
Very
High || <50 || <80 | | ≥50 | | ≥80
Ⅱ 忄ⅡⅡⅡⅡⅡ Page 2
| |
Name : Mr.
Lab No. DUMMY : Age : 25 Years
Ref By WM17SPF Gender : Male
Collected : SELF Reported : 17/1/2024 10:55:48AM
A/c Status : 7/11/2023 Report Status : Revised
Collected at 11:08:00AM : P Processed at : LPL-NATIONAL REFERENCE LAB
: LPL-ROHINI (NATIONAL REFERENCE LAB) National Reference laboratory, Block E,
National Reference laboratory, Block E, Sector 18, Rohini, New Delhi -110085
Sector 18, ROHINI
DELHI 110085
Test Report
Test Name Results Units Bio. Ref. Interval
|------------ |-------------------- |-------------------- |---------------- |-------------------- |
| High | <70 | <100 | ≥70 | ≥100 |
|------------ |-------------------- |-------------------- |---------------- |-------------------- |
| Moderate | <100 | <130 | ≥100 | ≥130 |
|------------ |-------------------- |-------------------- |---------------- |-------------------- |
| Low | <100 | <130 | ≥130* | ≥160* |
*In low risk patient, consider therapy after an initial non-pharmacological intervention for at least 3 months
GLUCOSE, FASTING (F)
Glucose Fasting 80.00 mg/dL 70 - 100
(Hexokinase)
VITAMIN B12; CYANOCOBALAMIN
(CLIA)
Vitamin B12; Cyanocobalamin 400.00 pg/mL 211.00 - 911.00
VITAMIN D, 25 - HYDROXY, SERUM
(CLIA)
Vitamin D, 25 Hydroxy 150.00 nmol/L 75.00 - 250.00
Interpretation
LEVEL | REFERENCE RANGE IN nmol/L| COMMENTS
--------------- |-------------------------- |-------------------------------------------------
Deficient | < 50 | High risk for developing bone disease
--------------- |-------------------------- |-------------------------------------------------
Insufficient | 50-74 | Vitamin D concentration which normalizes
| | Parathyroid hormone concentration
Sufficient | 75-250 | Optimal concentration for maximal health benefit
--------------- |-------------------------- |-------------------------------------------------
Potential | >250 | High risk for toxic effects
intoxication | |
Note
· The assay measures both D2 (Ergocalciferol) and D3 (Cholecalciferol) metabolites of vitamin D.
· 25 (OH)D is influenced by sunlight, latitude, skin pigmentation, sunscreen use and hepatic function.
· Optimal calcium absorption requires vitamin D 25 (OH) levels exceeding 75 nmol/L.
· It shows seasonal variation, with values being 40-50% lower in winter than in summer.
Ⅱ 忄ⅡⅡⅡⅡⅡⅡⅡ Page 3
Name : Mr.
Lab No. DUMMY : Age : 25 Years
Ref By WM17SPF Gender : Male
Collected : SELF Reported : 17/1/2024 10:55:48AM
A/c Status : 7/11/2023 Report Status : Revised
Collected at 11:08:00AM : P Processed at : LPL-NATIONAL REFERENCE LAB
: LPL-ROHINI (NATIONAL REFERENCE LAB) National Reference laboratory, Block E,
National Reference laboratory, Block E, Sector 18, Rohini, New Delhi -110085
Sector 18, ROHINI
DELHI 110085
Test Report
Test Name Results Units Bio. Ref Interval
· Levels vary with age and are increased in pregnancy.
· A new test Vitamin D, Ultrasensitive by LC-MS/MS is also available
THYROID PROFILE,TOTAL, SERUM
(CLIA)
T3, Total 1.00 ng/mL 0.60 - 1.81
T4, Total 7.00 µg/dL 5.01 - 12.45
TSH 3.00 µIU/m 0.550 - 4.780
Note
1. TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a
minimum between 6-10 pm . The variation of the order of 50% . hence time of the day has
influence on the measured serum TSH concentrations.
2. Alteration in concentration of Thyroid hormone binding protein can profoundly affect Total T3 and/or
Total T4 levels especially in pregnancy and in patients on steroid therapy.
3. Unbound fraction ( Free,T4 /Free,T3) of thyroid hormone is biologically active form and correlate
more closely with clinical status of the patient than total T4/T3 concentration
4. Values <0 uIU/mL need to be clinically correlated due to presence of a rare TSH variant in
some individuals
Ⅱ 忄ⅡⅡⅡⅡⅡⅡⅡ Page 4
Name : Mr.
Lab No. DUMMY : Age : 25 Years
Ref By WM17SPF Gender Male
Collected : SELF Reported : 17/1/2024 10:55:48AM
A/c Status : 7/11/2023 Report Status Revised
Collected at 11:08:00AM : P Processed at : LPL-NATIONAL REFERENCE LAB
: LPL-ROHINI (NATIONAL REFERENCE LAB) : National Reference laboratory, Block E,
National Reference laboratory, Block E, Sector 18, Rohini, New Delhi -110085
Sector 18, ROHINI
:
DELHI 110085
Test Report
Test Name Results Units Ref. Interval
HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD
(HPLC, NGSP certified)
HbA1c 10.0 % 4.00 - 5.60
Estimated average glucose (eAG) 240 mg/dL
Interpretation
HbA1c result is suggestive of Diabetes/ Higher than glycemic goal in a known Diabetic patient.
Please note, Glycemic goal should be individualized based on duration of diabetes, age/life expectancy,
comorbid conditions, known CVD or advanced microvascular complications, hypoglycaemia unawareness,
and individual patient considerations
Interpretation as per American Diabetes Association (ADA) Guidelines
Reference Group Non diabetic At risk Diagnosing Therapeutic goals
adults >=18 years (Prediabetes) Diabetes for glycemic control
HbA1c in % | 4.0-5.6 | 5.7-6.4 | >= 6.5 | <7.0
Note: Presence of Hemoglobin variants and/or conditions that affect red cell turnover must be considered,
particularly when the HbA1C result does not correlate with the patient’s blood glucose levels.
FACTORS THAT INTERFERE WITH FACTORS THAT AFFECT
HbA1C MEASUREMENT INTERPRETATION OF HBA1C RESULTS
Hemoglobin variants,elevated fetal | Any condition that shortens erythrocyte
hemoglobin (HbF) and chemically | survival or decreases mean erythrocyte
modified derivatives of hemoglobin (e.g. | age (e.g.,recovery from acute blood loss, |
carbamylated Hb in patients with renal hemolytic anemia, HbSS, HbCC, and HbSC)
failure) can affect the accuracy of | will falsely lower HbA1c test results
HbA1c measurements | regardless of the assay method used.Iron |
deficiency anemia is associated with
| higher HbA1c
Ⅱ 忄ⅡⅡⅡⅡⅡⅡⅡ Page 5
Name : Mr.
Lab No. DUMMY : Age : 25 Years
Ref By WM17SPF Gender : Male
Collected : SELF Reported 17/1/2024 10:55:48AM
:
A/c : 7/11/2023 Report Status Revised
:
Status 11:08:00AM : P Processed at
: LPL-NATIONAL REFERENCE LAB
Collected at : LPL-ROHINI (NATIONAL REFERENCE LAB) National Reference laboratory, Block E,
National Reference laboratory, Block E, Sector 18, Rohini, New Delhi -110085
Sector 18, ROHINI
DELHI 110085
Test Report
Test Name Results Units Bio. Ref. Interval
COMPLETE BLOOD COUNT; CBC
Hemoglobin 15.00 g/dL 13.00 - 17.00
(Photometry)
Packed Cell Volume (PCV) 45.00 % 40.00 - 50.00
(Calculated)
RBC Count 5.00 mill/mm3 4.50 - 5.50
(Electrical Impedence)
MCV 100.00 fL 83.00 - 101.00
(Electrical Impedence)
MCH 30.00 pg 27.00 - 32.00
(Calculated)
MCHC 33.00 g/dL 31.50 - 34.50
(Calculated)
Red Cell Distribution Width (RDW) 12.00 % 11.60 - 14.00
(Electrical Impedence)
Total Leukocyte Count (TLC) 5.00 thou/ mm3 4.00 - 10.00
(Electrical Impedence)
Differential Leucocyte Count (DLC)
(VCS Technology)
Segmented Neutrophils 50.00 % 40.00 - 80.00
Lymphocytes 40.00 % 20.00 - 40.00
Monocytes 5.00 % 2.00 - 10.00
Eosinophils 4.00 % 1.00 - 6.00
Basophils 1.00 % <2.00
Absolute Leucocyte Count
(Calculated)
Neutrophils 2.50 thou/ mm3 2.00 - 7.00
Lymphocytes 2.00 thou/ mm3 1.00 - 3.00
Monocytes 0.25 thou/ mm3 0.20 - 1.00
Eosinophils 0.20 thou/ mm3 0.02 - 0.50
Basophils ncil f Standa
0.05 dization thou/ mm3 0.02 - 0.10
Platelet Count 151 thou/ mm3 150.00 - 410.00
(Electrical impedence)
Mean Platelet Volume 6.5 fL 6.5 - 12.0
1. As per the
(Electrical recommendation of
Impedence) International cou r r in Hematology, the differential
Ⅱ 忄 ⅡⅡⅡ ⅡⅡⅡ
Note
Page 6
Name : Mr.
Lab No. DUMMY : Age : 25 Years
Ref By WM17SPF Gender : Male
Collected : SELF Reported 17/1/2024 10:55:48AM
:
A/c : 7/11/2023 Report Status Revised
:
Status 11:08:00AM : P Processed at
: LPL-NATIONAL REFERENCE LAB
Collected at : LPL-ROHINI (NATIONAL REFERENCE LAB) National Reference laboratory, Block E,
National Reference laboratory, Block E, Sector 18, Rohini, New Delhi -110085
Sector 18, ROHINI
DELHI 110085
Test Report
Test Name Results Units Bio. Ref. Interval
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood
2. Test conducted on EDTA whole blood
Dr Ajay Gupta Dr Gurleen Oberoi Dr Himangshu Mazumdar Dr Jatin Munjal
MD, Pathology DM(Hematopathology), MD, Biochemistry MD,Pathology
Technical Director - Hematology & MD,DNB,MNAMS Consultant Biochemist Consultant Pathologist
Immunology Senior Consultant and Lead- Dr Lal PathLabs Ltd Dr Lal PathLabs Ltd
NRL - Dr Lal PathLabs Ltd Hematopathology
NRL - Dr Lal PathLabs Ltd
Dr.Kamal Modi Dr Nimmi Kansal Dr Sarita Kumari Lal Dr Sunanda
MD, Biochemistry MD, Biochemistry MD, Pathology MD, Pathology
Consultant Biochemist Technical Director - Clinical Chemistry Consultant Pathologist Sr. Consultant Pathologist -
NRL - Dr Lal PathLabs Ltd & Biochemical Genetics Dr Lal PathLabs Ltd Hematology & Immunology
NRL - Dr Lal PathLabs Ltd NRL - Dr Lal PathLabs Ltd
This is a revised report & supersedes all the previously issued reports
I.;;;.II!I.III:II.I:I.:I. ;:■:!.::.I: !
I:!I. I.;;;.I
I.:::.II.:.::;.I!:I;I:.I.:.I!;.I:I.;.III
I.I.:::.I : :II!: I.:.II!.:.I:I:I.:II:I!I:::
!I.:I.:::I■;!::..■ !I .
.:I:..II:!:;I:■I■ :I .;■■II:.:.:.I:.I
!.::.I:::!: .!I.I: .II■.II.:.:!:!II!:.I!
I:I.!.II:.I:;I:.:: :: !. .:.!
■::I;II:I ;II■:!::;:I:II:;!....:!!:II■I
I;I:;II :. I!I!I.:.I:I:.I■I.!
I!:■II.:.I:I;I■.!I:::.:::I.:.I:..: ::: !
I::II::II:I.II.I!::;I:■II!;!
I.::.II:!!!:I.II■ !:I:II:::
I■:I■.II:I: I:;:: .!I::.:IIII:.!III!
II:..! IIII:I:I:II:.:III■I!:■II ■!:.:.
:..II: I.I :I.II;.!
:I:I.I:III;I.I.■.I:II;.: ■I::.■.::.!
III..:I.■::I::..■
I..:..;.!;I ::;I;I:I.:III.:.I::.I:::.■. ..
:II.:.I! ■ IIIIIII■....!..II:I;■I!.II!
II.:III..I.■!I!..!:IIII
....... . ... .. . . ... . ... . . ... . . .
IMPORTANT INSTRUCTIONS
Test results released pertain to the specimen submitted . All test results are dependent on the quality of the sample received by the Laboratory .
Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician . Report
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted . Certain tests may require further testing at additional cost
for derivation of exact value. Kindly submit request within 72 hours post reporting. Test results may show interlaboratory variations . The
Courts/Forum at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s). Test results are not
valid for medico legal purposes. This is computer generated medical diagnostic report that has been validated by Authorized
Medical Practitioner/Doctor. The report does not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: [email protected]
National Reference lab, Delhi, a CAP (7171001) Accredited, ISO 9001:2015 (FS60411) & ISO 27001:2013 (616691) Certified laboratory.
Ⅱ 忄ⅡⅡⅡⅡⅡⅡⅡ Page 7
